T Effector Gene Signature on IMpower150: Is There a Better Biomarker than PD-L1 for Immunotherapy? (BMIC-021)

Dr. Jack West reviews provocative biomarker results on the IMpower150 trial that tested atezolizumab with carboplatin/paclitaxel +/- bevacizumab & revealed strongest benefit of atezo in those with... Author: BeaconMedIC Added: 12/22/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts